Dr. Lamble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-2000
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Hematology/Oncology, 2014 - 2017- Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 2011 - 2014
University of Kansas School of MedicineClass of 2011
Certifications & Licensure
OR State Medical License 2014 - Present
WA State Medical License 2017 - 2026
AK State Medical License 2021 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia Start of enrollment: 2020 Jan 22
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry Start of enrollment: 2022 Jul 01
Roles: Contact
Publications & Presentations
PubMed
- Development of ALL-Hematotox (ALL-HT): Predicting post CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia.Monica S Nair, Sara K Silbert, Kai Rejeski, Karilynn A Wilson, Adam Joseph Lamble
Blood. 2024-11-19 - -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy.Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, Constance M Yuan, Alyssa Doverte
Journal for Immunotherapy of Cancer. 2024-10-26 - Feasibility and Favorable Responses Following Investigational CAR T-Cell Therapy for Relapsed and Refractory Infant ALL.Colleen Annesley, Adam J Lamble, Corinne Summers, Michael A Pulsipher, Alan S Wayne
Blood Advances. 2024-08-12
Journal Articles
- Research Paper Integrated Functional and Mass Spectrometry-Based Flow Cytometric Phenotyping to Describe the Immune Microenvironment in Acute Myeloid LeukemiaAdam Lamble, MD, ScienceDirect
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
